TMO - Thermo Fisher Scientific Inc.
NYSE - NYSE Delayed price. Currency in USD
Currency in USD
Valuation measures4
| Market cap (intra-day) | 200.88B |
| Enterprise value | 232.65B |
| Trailing P/E | 33.95 |
| Forward P/E | 21.88 |
| PEG ratio (5-yr expected) | 3.84 |
| Price/sales (ttm) | 4.66 |
| Price/book (mrq) | 4.75 |
| Enterprise value/revenue | 5.31 |
| Enterprise value/EBITDA | 21.29 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.79 |
| 52-week change 3 | -3.53% |
| S&P500 52-week change 3 | 6.21% |
| 52-week high 3 | 611.06 |
| 52-week low 3 | 475.77 |
| 50-day moving average 3 | 546.92 |
| 200-day moving average 3 | 546.37 |
Share statistics
| Avg vol (3-month) 3 | 1.45M |
| Avg vol (10-day) 3 | 2.14M |
| Shares outstanding 5 | 385.72M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 384.94M |
| % held by insiders 1 | 0.19% |
| % held by institutions 1 | 92.51% |
| Shares short (14 May 2023) 4 | 3.01M |
| Short ratio (14 May 2023) 4 | 1.87 |
| Short % of float (14 May 2023) 4 | 0.78% |
| Short % of shares outstanding (14 May 2023) 4 | 0.78% |
| Shares short (prior month 13 Apr 2023) 4 | 2.95M |
Dividends & splits
| Forward annual dividend rate 4 | 1.4 |
| Forward annual dividend yield 4 | 0.27% |
| Trailing annual dividend rate 3 | 1.25 |
| Trailing annual dividend yield 3 | 0.24% |
| 5-year average dividend yield 4 | 0.22 |
| Payout ratio 4 | 8.15% |
| Dividend date 3 | 13 Jul 2023 |
| Ex-dividend date 4 | 13 Jun 2023 |
| Last split factor 2 | 3:2 |
| Last split date 3 | 05 Jun 1996 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 31 Mar 2023 |
Profitability
| Profit margin | 13.75% |
| Operating margin (ttm) | 17.05% |
Management effectiveness
| Return on assets (ttm) | 4.98% |
| Return on equity (ttm) | 14.44% |
Income statement
| Revenue (ttm) | 43.81B |
| Revenue per share (ttm) | 112.18 |
| Quarterly revenue growth (yoy) | -9.40% |
| Gross profit (ttm) | 19B |
| EBITDA | 10.85B |
| Net income avi to common (ttm) | 6.02B |
| Diluted EPS (ttm) | 15.33 |
| Quarterly earnings growth (yoy) | -41.80% |
Balance sheet
| Total cash (mrq) | 3.48B |
| Total cash per share (mrq) | 9.03 |
| Total debt (mrq) | 35.34B |
| Total debt/equity (mrq) | 83.28 |
| Current ratio (mrq) | 1.27 |
| Book value per share (mrq) | 109.55 |
Cash flow statement
| Operating cash flow (ttm) | 7.68B |
| Levered free cash flow (ttm) | 4.6B |
© 2023 Yahoo. All rights reserved.